Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases.

Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases.
复制标题

面向临床医生的呼吸组学:挥发性有机化合物在呼吸系统疾病中的应用

DOI:
10.1136/thoraxjnl-2020-215667
复制
发表时间:
2021-05
期刊:
影响因子:
10
通讯作者:
Greening NJ
Greening NJ
中科院分区:
医学1区
文献类型:
--
作者:
Ibrahim W;Carr L;Cordell R;Wilde MJ;Salman D;Monks PS;Thomas P;Brightling CE;Siddiqui S;Greening NJ

文献摘要

参考文献

被引文献

相似文献

呼气分析有可能通过体循环提供有关肺部局部和其他重要器官中发生的各种代谢途径的状态的有价值的见解。多年来,挥发性有机化合物(VOCs)已被提出作为可行的替代诊断和预后的生物标志物为不同的呼吸道病理。我们回顾了目前已发表的文献中发现的呼出气挥发性有机化合物及其利用在各种呼吸系统疾病的临床呼气测试的发展中的关键障碍,包括缺乏统一的共识,呼气收集和分析和理解之间的关系的复杂性呼出的挥发性有机化合物和潜在的代谢途径。我们提出了一个全面的概述,根据出版的文献和我们的经验,从协调国家呼吸组学中心,迄今取得的进展和一些关键的挑战,在该领域和克服它们的方法。我们特别关注呼吸组学与临床医生的相关性,以及它为诊断和疾病监测带来的宝贵见解。Breathomics具有很大的前景,我们的研究结果值得使用标准化协议进行进一步的大规模多中心诊断研究,以帮助将这项新技术定位于呼吸系统疾病诊断的中心。
Exhaled breath analysis has the potential to provide valuable insight on the status of various metabolic pathways taking place in the lungs locally and other vital organs, via systemic circulation. For years, volatile organic compounds (VOCs) have been proposed as feasible alternative diagnostic and prognostic biomarkers for different respiratory pathologies. We reviewed the currently published literature on the discovery of exhaled breath volatile organic compounds and their utilisation in various respiratory diseases Key barriers in the development of clinical breath tests include the lack of unified consensus for breath collection and analysis and the complexity of understanding the relationship between the exhaled VOCs and the underlying metabolic pathways. We present a comprehensive overview, in light of published literature and our experience from co-ordinating a national breathomics centre, of the progress made to date and some of the key challenges in the field and ways to overcome them. We particularly focus on the relevance of breathomics to clinicians and the valuable insights it adds to diagnostics and disease monitoring. Breathomics holds great promise and our findings merit further large-scale multicentre diagnostic studies using standardised protocols to help position this novel technology at the centre of respiratory disease diagnostics.
DOI: 10.2147/copd.s76212
发表时间: 2015
影响因子: 2.8
作者:
Besa V;Teschler H;Kurth I;Khan AM;Zarogoulidis P;Baumbach JI;Sommerwerck U;Freitag L;Darwiche K
通讯作者: Darwiche K
DOI: 10.1371/journal.ppat.1003311
发表时间: 2013-05
期刊: PLoS pathogens
影响因子: 6.7
作者:
Bos LD;Sterk PJ;Schultz MJ
通讯作者: Schultz MJ
DOI: 10.1016/j.clinms.2018.02.003
发表时间: 2018-01-01
影响因子: 2.1
作者:
Bregy, Lukas;Nussbaumer-Ochsner, Yvonne;Zenobi, Renato
通讯作者: Zenobi, Renato
DOI: 10.1002/cbdv.200590062
发表时间: 2005-01-01
影响因子: 2.9
作者:
Dickschat, JS;Martens, T;Schulz, S
通讯作者: Schulz, S
DOI: 10.1088/1752-7163/aa8a46
发表时间: 2018-01-01
影响因子: 3.8
作者:
Doran, Sophie L. F.;Romano, Andrea;Hanna, George B.
通讯作者: Hanna, George B.